Markets
BSE See NSE See 39,106.97
146.18 (0.38%)
collapse Related Readings collapse

Stock Pick From The Personal Care Segment

| 1/10/2013 9:00 PM Thursday

Choice Scrip is a Blue Chip stock pick that is expected to give returns within a 6 months-1 year horizon. The recommendation is based on a fundamental analysis of the company.

The company recommended as the Choice Scrip for this issue is a 76-year old firm almost synonymous with the oral care segment in India.

Here Is Why:

  • Colgate is a market leader in the oral care segment which enjoys a strong brand recall.
  • It focuses on innovation and rising rural demand will drive its financials going ahead.
  • It has shown healthy financial performance in the past, which has made it a true wealth creator.

There are very few brands in the market which are so famous that they become synonymous to the products. One such brand is Colgate, which is used interchangeably with oral care products. What goes most in favour of the company is the power of a strong brand and an excellent product. Colgate Palmolive enjoys an excellent brand recall, and has the highest market share in the oral care segment which is reflected well in its financial performance. Its zero debt status is another added advantage. These are precisely the factors which go in favour of recommending this stock to our readers once again.

Colgate was incorporated way back in 1937, which makes it a more than 76 year-old company. It operates in various segments like Oral Care, Personal Care, Home Care and Professional Oral Care, and has strong brands like Colgate Dental Cream, Colgate Active Salt and various others brands under its belt. However, Oral Care is the company’s core segment as it contributes to more than 90 per cent of its revenues. It is a market leader in toothpastes and the toothbrush segment with a market share (volume) of 54.3 per cent and 39 per cent respectively (as of September 30, 2012 ).

LAST FIVE QUARTERS (Rs/Cr)
ParticularsSep 12Jun 12Mar 12Dec 11Sep 11
Net Sales 773.77 736.08 685.94 669.57 675.54
Consumption of Raw Materials 257.89 226.09 227.51 234.57 224.01
Admin. And Selling Expenses 88.92 83.72 58.32 107.49 114.29
P/L Before Other Inc. , Int., Excpt. Items & Tax 165.18 151.94 159.83 139.37 120.22
Tax 34.97 45.74 42.01 32.96 29.26
Net Profit/(Loss)  145.08 117.42 130.77 115.58 99.68
Equity Share Capital 13.6 13.6 13.6 13.6 13.6

The company’s brands are widely distributed and are available across 4.85 million retail outlets. Such a wide reach of distribution along with higher disposable incomes in rural areas will result into higher demand which will drive the company’s topline. It also focuses on innovation which will further its growth going ahead. In FY12, some of the major products like Colgate Sensitive Pro-Relief and variants of plax mouth wash were introduced by the company, which have been accepted quite well by consumers.

Colgate is also expanding its manufacturing facilities which will help it to support its growth momentum. It is opening up two manufacturing facilities for toothpastes and for toothbrushes in Gujarat and Andhra Pradesh respectively, which are expected to be operational in 2013.

SHAREHOLDING PATTERN AS ON 30/9/2012
Promoters 51
Banks Fin. Inst. and Insurance 4.83
FII 20.86
General Public 20.61
Others 2.7

Sound brand value and good fundamentals are one thing and creating value for stakeholders just another. Colgate has created immense value for its stakeholders and this is vindicated from the returns it has generated since 1978. It came up with an IPO in 1978 and if investors had purchased 250 shares costing around Rs 6250, at the current market price, they would be sitting on approximately 14080 shares (adjusted for bonus and right issues) worth Rs 2.48 crore. This means a CAGR of 28 per cent (including dividend) over the past 35 years.

For the September quarter of 2012, its topline grew by 17.5 per cent to Rs 792 crore (with a volume growth of 10 per cent) while the bottomline grew at a robust rate of 45 per cent to Rs 145 crore on a YoY basis. Stock adjustments have led to improved EBITDA margins, which were up 279 basis points to 22.18 per cent. Colgate’s EBITDA margins are one of the best in the industry.

For FY13, it has already declared two interim dividends aggregating to a total of Rs 19 per share. On the valuations front, the company is currently trading at a trailing PE multiple of 42x. Given the growth prospects and the leadership position that it enjoys, Colgate is justifiably commanding this kind of premium. We believe the company would be posting robust growth numbers going ahead, and hence, one should invest in the counter.

 BEST OF LAST ONE YEAR
Company NameReco. Price (Rs)CMP(Rs)
Gain (%)
Ajanta Pharma 171.00 404.00 136.26
ING Vysya Bank  325.00 566.00 74.15
M&M Financial Services   685.35 1192.00 73.93
Colgate Palmolive (India), 1014.00 1544.00 52.27
GlaxoSmith Kline Consumer Healthcare 2542.00 3858.00 51.77
Strides Arcolab  729.05 1082.00 48.41
Asian Paints  2985.00 4384.00 46.87
Jammu & Kashmir Bank   976.00 1316.00 34.84

 

Find More Articles on: DSIJ Magazine, Choice Scrip, Stock Recommendations, Fundamental Picks, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.